Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
BMY similar filings
- 20 May 20 Registration of securities issued in business combination transactions
- 20 Feb 19 Registration of securities issued in business combination transactions (amended)
- 1 Feb 19 Registration of securities issued in business combination transactions (amended)
- 1 Feb 19 Registration of securities issued in business combination transactions
- 28 Jun 04 Registration of securities issued in business combination transactions (amended)
- 24 May 04 Registration of securities issued in business combination transactions (amended)
- 31 Mar 04 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.4
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the registration statement on Form S-4 and related joint proxy statement/prospectus filed by Bristol-Myers Squibb Company and to the incorporation by reference therein of our report dated March 1, 2018, with respect to the consolidated financial statements of Juno Therapeutics, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2017, and included in Celgene Corporation’s Current Report on Form 8-K/A dated May 18, 2018, both filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Seattle, Washington
January 30, 2019